PPAR gamma agonists inhibit angiogenesis by suppressing PKC alpha- and CREB-mediated COX-2 expression in the human endothelium

Torna indietro

Abstract

The activation of peroxisome proliferator-activated receptor (PPAR)? is known to inhibit angiogenesis. As a potential mechanism for this, we aimed at examining the effects of PPAR? agonists on the pro-angiogenic enzyme cyclooxygenase (COX)-2 in human endothelium.Methods and results Cultured endothelial cells were pre-incubated with the PPAR? agonists rosiglitazone (RSG) or GW1929 before stimulation with vascular endothelial growth factor (VEGF) or phorbol myristate acetate (PMA). RSG and GW1929 attenuated VEGF- and PMA-stimulated COX-2 activity, as well as protein and mRNA expression. This effect was abolished by the PPAR? antagonists bisphenol A diglycidyl ether and GW9662 as well as by PPAR? small-interfering RNAs (siRNAs). Transient transfection experiments revealed that the induction of COX-2 promoter was significantly inhibited by RSG through an interference with the cAMP response element (CRE) site. COX-2 downregulation after siRNA targeting CRE-binding protein (CREB) confirmed the role of CREB in mediating COX-2 transcription. Correspondingly, PPAR? agonists attenuated CREB activation. As both protein kinase C (PKC)? and ? are involved in VEGF-induced COX-2 expression and CREB activation, we investigated which isoform(s) of PKC was affected by RSG. RSG only reduced VEGF- and PMA-stimulated PKC? membrane translocation.Conclusion VEGF induces CREB-mediated COX-2 expression through a PKC?-dependent pathway in human endothelium. The anti-angiogenic effect of PPAR? agonists is due, at least in part, to an interference with the VEGF-stimulated PKC?-mediated activation of CREB and the related expression of COX-2.

Autore Pugliese

Tutti gli autori

  • Scoditti E.; Massaro M.; Carluccio M.A.; Distante A.; Storelli C.; De Caterina R.

Titolo volume/Rivista

Cardiovascular research

Anno di pubblicazione

2010

ISSN

0008-6363

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile